Invoice Requirement. Unless otherwise specified herein, any amounts payable to Infinity hereunder shall be made in U.S. dollars within forty-five (45) calendar days after receipt by Novartis, or its nominee designated for that purpose in advance by Novartis in writing to Infinity, of an invoice (in the form attached as Exhibit D) covering such payment.
Invoice Requirement. Any amounts payable to Vertex hereunder shall be made within thirty days after receipt by CFFT, or its nominee designated for that purpose in advance by CFFT in writing to Vertex, of an invoice covering such payment.
Invoice Requirement. Any amounts payable to VERTEX hereunder (except any royalty payments required to be made under the provisions of Section 6.3 of the License Agreement) shall be made within thirty days after receipt by NOVARTIS, or its nominee designated for that purpose in advance by NOVARTIS in writing to VERTEX, of an invoice covering such payment, which invoice shall conform to the extent reasonably practicable to the form of invoice contained in Exhibit B to this Research Agreement.
Invoice Requirement. Invoicing for Call Orders shall be submitted in accordance with the BPA terms and conditions, Call Order clauses and requirements. Invoicing may commence upon acceptance of each or all deliverables by an authorized official Invoicing shall include all supporting documents for the invoiced amount.
Invoice Requirement. Any amounts payable to Myogen hereunder (except any royalty payments required to be made under the provisions of Article IV of the License Agreement) shall be made within thirty (30) days after receipt by NIBRI, or its nominee designated for that purpose in advance by NIBRI in writing to Myogen, of an invoice covering such payment. [Signature page follows] [/\#/\]CONFIDENTIAL TREATMENT REQUESTED Collaboration and Option Agreement - Confidential - Page 41 MYOGEN, INC. By: /s/ J. William Freytag ---------------------------------------------- J. William Freytag Title: President axx Xxxxx Xxxxxxive Officer NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. By: /s/ Mark Fishman ---------------------------------------------- Mark Fishman, M.D. Title: Presidenx xxx Xxxxx Executive Officer [/\#/\]CONFIDENTIAL TREATMENT REQUESTED Collaboration and Option Agreement - Confidential - Page 42 SCHEDULE 1.24
Invoice Requirement. 58 15.18 Hardship........................................................58 SCHEDULES Schedule 1.12 -- List of Drug Product Candidates Schedule 1.25 -- List of Major Markets Schedule 1.29 -- NOVARTIS Patents Schedule 1.44 -- VERTEX Patents Schedule 4.6 -- Terms of Supply License, Development and Commercialization Agreement -- Confidential -- Table of Contents -- Page iii License, Development and Commercialization Agreement This Agreement is made and entered into as of ________, _____ (the "Effective Date") between Vertex Pharmaceuticals Incorporated (hereinafter "VERTEX"), a Massachusetts corporation with principal offices at 000 Xxxxxxx Xxxxxx, Xxxxxxxxx, XX 00000-0000, and NOVARTIS PHARMA AG (hereinafter "NOVARTIS"), a Swiss corporation with principal offices at XX-0000 Xxxxx, Xxxxxxxxxxx.
Invoice Requirement. Any amounts payable to Myogen hereunder (except any royalty payments required to be made under the provisions of Article IV of the License Agreement) shall be made within thirty (30) days after receipt by NIBRI, or its nominee designated for that purpose in advance by NIBRI in writing to Myogen, of an invoice covering such payment.
Invoice Requirement. The Agency shall pay the Provider on the basis of monthly invoices submitted to the Agency contract manager in a manner that is acceptable to the Agency (see Exhibit C).
Invoice Requirement. Contractor will be paid on the basis of, and in response to, separate monthly invoices submitted by Contractor to each HFC Parking Manager, subject to their individual review and approval. Each such invoice shall (i) be Parking Facility-specific (expect to the extent HFC directs the Contractor to combine Parking Facilities); (ii) include a prorated (i.e., 1/12th) portion of the Management Fee, (iii) detail all Services performed; (iv) itemize each position, actual labor hours expended and the correct hourly Labor Rate payable by HFC; (v) itemize and detail any Reimbursable Expenses, and include all supporting documentation confirming that such amounts are invoiced at cost and procured in accordance with Section 3.5 of this Agreement; and (vi) include such other detail as HFC may require.
Invoice Requirement. Except as otherwise set forth in Section 6.1, any amounts payable to Hybridon hereunder shall be made within sixty (60) calendar days after receipt by Novartis or its designated nominee of an invoice covering such payment. With respect License, Development and Commercialization Agreement - Confidential PAGE 41 OF 53 to invoices for milestone payments, Hybridon shall send such invoices following written notice by Novartis that the particular milestone(s) to which such invoice pertains has been met.
